Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics
Sipos, O.; Török, A.; Kalic, T.; Duda, E.; Filkor, K. Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics. Antibodies 2015, 4, 123-140. https://doi.org/10.3390/antib4020123
Sipos O, Török A, Kalic T, Duda E, Filkor K. Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics. Antibodies. 2015; 4(2):123-140. https://doi.org/10.3390/antib4020123
Chicago/Turabian StyleSipos, Orsolya, Annamária Török, Tanja Kalic, Ernő Duda, and Kata Filkor. 2015. "Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics" Antibodies 4, no. 2: 123-140. https://doi.org/10.3390/antib4020123